| HOME >> BIOLOGY >> TECHNOLOGY |
Total current assets 7,889,612 1,694,159
Total property, plant and equipment, net 1,034,835 968,737
Other Assets
Prepaid consulting - 13,011
Deposits - 9,744
Patents 2,016,391 2,176,388
Total assets $10,940,838 $4,862,039
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable $596,132 $422,753
Accrued liabilities 126,141 77,228
Deferred revenue 256,793 -
Taxes payable 2,400 2,400
Total current liabilities 981,466 502,381
Deferred rent 15,798 -
Total liabilities 997,264 502,381
Stockholders' Equity
Preferred Stock, no par value:
5,000,000 shares authorized,
no shares issued - -
Class A common stock, no par value:
50,000,000 shares authorized
24,961,805 issued and outstanding at
July 31, 2007, and 29,573,936 issued
and outstanding at July 31, 2008 35,436,077 26,519,543
Additional Paid-In Capital 4,155,608 2,486,829
Warrants:
391,698 issued and outstanding at
July 31, 2007, and 880,351 issued
and outstanding at July 31, 2008 1,766,159 245,825
Accumulated other comprehensive income 18,588 -
'/>"/>| SOURCE PURE Bioscience Copyright©2008 PR Newswire. All rights reserved |